Keeping in mind that HuR has been recently found to be implicated in chemoresistance mechanisms to therapeutic drugs, such as tamoxifen [103, 104]; strategies to reduce HuR protein levels could be a promising therapeutic approach in controlling tumour progression. Here, ELAVL1 is linked to neoplasm.